MedStar Authors catalog › Details for: A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey.
Normal view MARC view ISBD view

A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey.

by Van Nostrand, Douglas; Wu, Di; Hall, Jordan; Khorjekar, Gauri; Zeymo, Alexander; Brennan, Michael T.
Citation: Unpublished 2017/05/01/.Published: 2017Conference: MedStar Health Research Symposium, , North Bethesda, MD., Full author list: Van Nostrand D; Wu D; Hall J; Khorjekar G; Zeymo A; Brennan MT; McIver B; Bloom G.Local accession number: A2017_050.Institution(s): MedStar Washington Hospital Center | MedStar Health Research InstituteDepartment(s): Medicine/Nuclear MedicineActivity type: Poster Presentation.

Powered by Koha